A Feasibility Study of a Suicide Prevention Video
A Pilot Study of the Effectiveness of a Suicide Prevention Video Tool to Reduce the Incidence of Active Suicide Behavior in Individuals With Psychiatric Illness
1 other identifier
interventional
60
1 country
1
Brief Summary
This initial study is a pilot feasibility study with a primary objective of assessing the feasibility of a larger study by evaluating the procedures and methodology, as well as collecting pilot data. The eventual research goal is to demonstrate whether a suicide prevention video in addition to standard care for suicidality is an effective strategy to reduce suicidal behaviours in individuals with a history of such. The suicide prevention video is developed as an educational tool to inform participants of the various consequences of suicide as well as giving a message of hope. It is hoped that such an approach will help to reduce future suicidal behaviours in those who have a history of such. If so, then this could be made as a part of the standard of care in treating patients with suicidality.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2017
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 23, 2016
CompletedStudy Start
First participant enrolled
January 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2020
CompletedFirst Posted
Study publicly available on registry
November 15, 2021
CompletedNovember 15, 2021
November 1, 2021
3.4 years
August 23, 2016
November 3, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
An assessment of suicidal behaviours following the use of a video intervention
To assess the change in suicidality of patients admitted for such using the Modified Scale for Suicidal Ideation after being given an educational video explaining common misinformation about suicide.
12 months
Secondary Outcomes (1)
Mean change from baseline in the expression of suicidal ideation on the Modified Scale for Suicidal Ideation at 48 hours, 3 months and 6 months
12 months
Study Arms (2)
Suicide prevention video
EXPERIMENTALIn this group, in addition to receiving the standard of care for their suicidality, the participants will also view a suicide prevention video.
Standard suicide treatment
ACTIVE COMPARATORIn this group, participants will only receive the standard of care for their suicidality, which can include medications and/or therapy. The care will be determine by their attending physician.
Interventions
The video has been developed by the research team as an educational tool to teach patients about suicide, the consequences of such and imparting a message of hope.
The standard suicide treatment will be determine by the attending physician and can include medications and/or psychotherapy
Eligibility Criteria
You may qualify if:
- Age 19 years or older
- Admitted to the Royal Columbian Hospital under psychiatric services
- Individuals will have had suicidal behaviours as part of their presentation leading to hospitalization
- Individuals must be at the level 2 observation privileges or higher
- Individuals must be capable of giving consent to participate in the study
- Individuals must speak and read English fluently Individuals admitted to the hospital as voluntary and involuntary (certified) patients
You may not qualify if:
- Individuals with hearing or visual deficits that impairs hearing or viewing the SPV
- Individuals who are under the influence of drugs, such as intoxication or active withdrawal
- Individuals with established diagnoses of cognitive impairment affecting their ability to give consent, understand what is expected of them in the study or follow directions
- Patients that require a substitute decision makers to provide consent
- Individuals whose behaviors an/or cognition are actively affected by ongoing psychosis, including hallucinations, delusions, and disorganized behaviors
- Individuals whose treating team assess them as likely to have a negative response to the SPV, for example paranoia around electronic devices
- Patient's who's attending physiatrist is one of the study team members
- Patients who are currently under the direct care of any of the investigators Patients that had acute suicidality in the last 24 hours
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Fraser Healthlead
Study Sites (1)
Royal Columbian and Eagle Ridge Hospitals
New Westminster, British Columbia, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hem Phaterpekar, MD
Fraser Health
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 23, 2016
First Posted
November 15, 2021
Study Start
January 1, 2017
Primary Completion
June 1, 2020
Study Completion
June 1, 2020
Last Updated
November 15, 2021
Record last verified: 2021-11
Data Sharing
- IPD Sharing
- Will not share